Immune Checkpoint Inhibitor–Induced Ocular Myasthenia Gravis: Case Series and Literature Review
ICI-OMG is a rare and distinct condition, presenting significant diagnostic challenges due to often negative antibody tests and variable sfEMG results. Early recognition of ICI-OMG in patients with ptosis and/or diplopia is crucial. Treatment responses vary, and most patients do not return to baseline, indicating ICI-OMG is likely chronic. Further research is needed to improve diagnostic markers and treatment strategies.
Authors
- Wayne T. Cornblath (ORCID: https://orcid.org/0009-0008-0978-5517)
- Victoria Dezard
- Edward Margolin (ORCID: https://orcid.org/0000-0002-6738-7225)
- Heather M. McDonald (ORCID: https://orcid.org/0000-0002-6270-6709)
Publication Details
- Journal
- Journal of Neuro-Ophthalmology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1097/wno.0000000000002330
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00